Funding Rounds
Hoba Therapeutics Series A (2023, $24M)
Hoba TherapeuticsTherapeutic protein developer for chronic neuropathic pain.
Summary
Stage: Series A
Raised Amount: $24.76M
Raised Date: 2023-10-01
Stage: Series A
Raised Amount: $24.76M
Raised Date: 2023-10-01
